Supernus announces Q3 2026 earnings call on Oct 29
Supernus Pharmaceuticals Inc. will report third quarter 2026 financial and business results after market close on Oct 29 and host a conference call at 4:30 p.m. ET featuring CEO Jack Khattar and CFO Tim Dec.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed